v3.26.1
Condensed Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
IPO
URO
Redeemable Convertible Preferred Stock
Common Stock
Common Stock
IPO
Common Stock
URO
Additional Paid-in Capital
Additional Paid-in Capital
IPO
Additional Paid-in Capital
URO
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance, Shares at Dec. 31, 2024       297,205,041                
Beginning balance at Dec. 31, 2024       $ 508,087                
Beginning balance, Shares at Dec. 31, 2024         2,446,864              
Beginning balance at Dec. 31, 2024 $ (311,183)       $ 2     $ 47,242       $ (358,427)
Issuance of common stock in connection with initial public offering/Issuance of common stock and pre-funded warrants to purchase common stock in connection with underwritten registered offering, net of issuance costs, Shares           8,750,000            
Issuance of common stock in connection with initial public offering/Issuance of common stock and pre-funded warrants to purchase common stock in connection with underwritten registered offereing, net of issuance costs   $ 124,598       $ 9     $ 124,589      
Conversion of redeemable convertible preferred stock to common stock upon initial public offering, Shares       (297,205,041)                
Conversion of redeemable convertible preferred stock to common stock upon initial public offering       $ (508,087)                
Conversion of redeemable convertible preferred stock to common stock upon initial public offering, Shares         32,586,823              
Conversion of redeemable convertible preferred stock to common stock upon initial public offering 508,087       $ 33     508,054        
Exercise of stock options, Shares         13,479              
Exercise of stock options 126             126        
Stock-based compensation expense 3,226             3,226        
Net Income (Loss) (32,786)                     (32,786)
Ending balance, Shares at Mar. 31, 2025         43,797,166              
Ending balance at Mar. 31, 2025 292,068       $ 44     683,237       (391,213)
Beginning balance, Shares at Dec. 31, 2024       297,205,041                
Beginning balance at Dec. 31, 2024       $ 508,087                
Beginning balance, Shares at Dec. 31, 2024         2,446,864              
Beginning balance at Dec. 31, 2024 (311,183)       $ 2     47,242       (358,427)
Net Income (Loss) (66,465)                      
Ending balance, Shares at Jun. 30, 2025         43,850,884              
Ending balance at Jun. 30, 2025 262,238       $ 44     687,086       (424,892)
Beginning balance, Shares at Mar. 31, 2025         43,797,166              
Beginning balance at Mar. 31, 2025 292,068       $ 44     683,237       (391,213)
Issuance of common stock under the 2025 Employee Stock Purchase Plan, Shares         53,716              
Issuance of common stock under the 2025 Employee Stock Purchase Plan 612             612        
Issuance of common stock upon vesting of restricted stock awards/Issuance of restricted stock, Shares         2              
Stock-based compensation expense 3,237             3,237        
Net Income (Loss) (33,679)                     (33,679)
Ending balance, Shares at Jun. 30, 2025         43,850,884              
Ending balance at Jun. 30, 2025 $ 262,238       $ 44     687,086       (424,892)
Beginning balance, Shares at Dec. 31, 2025 49,335,551       49,335,551              
Beginning balance at Dec. 31, 2025 $ 354,966       $ 49     844,354     $ 110 (489,547)
Exercise of stock options, Shares         402,067              
Exercise of stock options 4,079       $ 1     4,078        
Issuance of common stock upon vesting of restricted stock awards/Issuance of restricted stock, Shares         1              
Stock-based compensation expense 7,109             7,109        
Net unrealized loss on marketable securities (245)                   (245)  
Net Income (Loss) (24,208)                     (24,208)
Ending balance, Shares at Mar. 31, 2026         49,737,619              
Ending balance at Mar. 31, 2026 $ 341,701       $ 50     855,541     (135) (513,755)
Beginning balance, Shares at Dec. 31, 2025 49,335,551       49,335,551              
Beginning balance at Dec. 31, 2025 $ 354,966       $ 49     844,354     110 (489,547)
Net unrealized loss on marketable securities (545)                      
Net Income (Loss) $ (68,935)                      
Ending balance, Shares at Jun. 30, 2026 55,504,574       55,504,574              
Ending balance at Jun. 30, 2026 $ 453,124       $ 56     1,011,985     (435) (558,482)
Beginning balance, Shares at Mar. 31, 2026         49,737,619              
Beginning balance at Mar. 31, 2026 341,701       $ 50     855,541     (135) (513,755)
Issuance of common stock in connection with initial public offering/Issuance of common stock and pre-funded warrants to purchase common stock in connection with underwritten registered offering, net of issuance costs, Shares             5,540,000          
Issuance of common stock in connection with initial public offering/Issuance of common stock and pre-funded warrants to purchase common stock in connection with underwritten registered offereing, net of issuance costs     $ 144,569       $ 6     $ 144,563    
Exercise of stock options, Shares         143,698              
Exercise of stock options 1,696             1,696        
Issuance of common stock under the 2025 Employee Stock Purchase Plan, Shares         83,257              
Issuance of common stock under the 2025 Employee Stock Purchase Plan 998             998        
Stock-based compensation expense 9,187             9,187        
Net unrealized loss on marketable securities (300)                   (300)  
Net Income (Loss) $ (44,727)                     (44,727)
Ending balance, Shares at Jun. 30, 2026 55,504,574       55,504,574              
Ending balance at Jun. 30, 2026 $ 453,124       $ 56     $ 1,011,985     $ (435) $ (558,482)